B7-CTLA4 interaction promotes cognate destruction of tumor cells by cytotoxic T lymphocytes in vivo
- 15 April 2002
- journal article
- Published by American Society of Hematology in Blood
- Vol. 99 (8) , 2880-2889
- https://doi.org/10.1182/blood.v99.8.2880
Abstract
Costimulatory molecules B7-1 and B7-2 (hereby collectively called B7) interact with CD28 and CTLA4 on T cells and promote antitumor immunity. The function of B7-CTLA4 interaction in antitumor CTL response remains controversial. Here we used CD28−/− and CD28+/− or CD28+/+ transgenic mice that express the T-cell receptor specific for an unmutated tumor antigen, P1A, and for tumor cells expressing a CTLA4-specific B7 mutant to evaluate the function of CD28-B7 and CTLA4-B7 interactions in induction and effector phases of antitumor immunity. We report that B7-CD28 and B7-CTLA4 interactions promote tumor rejection. However, this is achieved by distinct mechanisms. B7-CD28 interaction enhances T-cell clonal expansion, though a role for this interaction in the effector phase cannot be ruled out. In contrast, B7-CTLA4 interaction enhances the CTL-mediated destruction of tumors, but not T-cell clonal expansion.Keywords
This publication has 50 references indexed in Scilit:
- Is CTLA-4 a negative regulator for T-cell activation?Immunology Today, 1997
- The Emerging Role of CTLA-4 as an Immune AttenuatorImmunity, 1997
- Duration of TCR Stimulation Determines Costimulatory Requirement of T CellsImmunity, 1996
- Intracellular Trafficking of CTLA-4 and Focal Localization Towards Sites of TCR EngagementPublished by Elsevier ,1996
- Mutational analysis and an alternatively spliced product of B7 defines its CD28/CTLA4-binding site on immunoglobulin C-like domain.The Journal of Experimental Medicine, 1995
- CTLA-4 can function as a negative regulator of T cell activationImmunity, 1994
- T cell costimulation by B7/BB1 induces CD8 T cell-dependent tumor rejection: an important role of B7/BB1 in the induction, recruitment, and effector function of antitumor T cells.The Journal of Experimental Medicine, 1994
- A major costimulatory molecule on antigen-presenting cells, CTLA4 ligand A, is distinct from B7.The Journal of Experimental Medicine, 1993
- Tumor Rejection After Direct Costimulation of CD8 + T Cells by B7-Transfected Melanoma CellsScience, 1993
- Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes.The Journal of Experimental Medicine, 1992